Global Health Commercialization and Funding Roundtable

The IfM has hosted the first Global Health Commercialization and Funding Roundtable.

The event brought together global health entrepreneurs from both developed and developing countries, investors/funders, civil society, member state representatives and academia to explore business models in discovery, development and delivery of global health innovations.


Amongst the attendees were David Brown, Adviser at One World Health, Patrick Gihana-Mulenga from Rwanda High Commission UK, Ann Ginsberg, MD Vice President of Scientific Affairs, Aeras, Suresh Jadhav, Executive Director, Serum Institute of India Ltd, Marc Lipman from the Royal Free Hospital, University of London, Bina Rawal, Head of Clinical Development at Wellcome Trust and Ellen Strahlman from GlaxoSmtihKline.

The idea for the Roundtable stemmed from the desire to match global health conversations in innovation and access with the resource providers who invest in innovation development from R&D to delivery.

The Roundtable examined current partnerships between resource providers and entrepreneurs and explored the dynamics of these relationships. In the context of tuberculosis, a major global health issue, the roundtable shared best practices in business models and promising innovations relating to vaccines, pharmaceuticals and diagnostic technologies.


Recordings of the day's events can be found here.

Date published

17 May 2012

Share This